Browse Category

Stock Market News 9 December 2025

BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies (BMNR) Stock Soars as Ethereum Treasury Hits 3.86 Million ETH – Latest News, Forecasts and Risks (Dec. 9, 2025)

BitMine Immersion Technologies, Inc. (NYSE American: BMNR) is back in the spotlight on December 9, 2025, as the Ethereum‑focused treasury stock jumps roughly 8% intraday after confirming it now controls about 3.86 million ETH—more than 3.2% of all Ethereum in circulation—and a combined crypto and cash hoard of roughly $13.2 billion. Nasdaq+1 The rally caps a frantic few weeks that have included: Below is a deep dive into what’s happening with BMNR today, how the business model has evolved, and what current forecasts and analyses are actually saying. BMNR stock today: price, valuation and volatility snapshot As of the afternoon
KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

KE Holdings (BEKE) Stock Slides as Buybacks Accelerate: What Q3 2025 Earnings and China’s Housing Slump Mean for Investors

Published 9 December 2025 KE Holdings Inc. (NYSE: BEKE), the Chinese online and offline housing platform behind Lianjia and Beike, is back in the spotlight as its stock trades lower today despite aggressive share repurchases and steady revenue growth. On Tuesday, BEKE gapped down at the open, sliding from a previous close of about $17.08 to an open near $16.35, with intraday trading around $16.27 and more than 1 million shares changing hands.MarketBeat In parallel, a Nasdaq/ETF Channel note highlighted that BEKE was among the notable decliners inside the Vanguard Total International Stock ETF (VXUS), with the stock down roughly
Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics (SMMT) Stock on December 9, 2025: Trial Optimism Collides With High Risk, High Volatility

Summit Therapeutics Inc. (NASDAQ: SMMT) continues to trade like a classic high-beta biotech: big promises in lung cancer, plenty of red flags, and a stock price stuck near the lower end of its 52-week range while analysts project eye-popping upside. As of the latest US session on December 9, 2025, SMMT is trading around $17–18 per share, versus a 52-week range of $15.55 to $36.91. That means the stock is much closer to its lows than its highs, despite a steady drumbeat of bullish analyst targets and positive trial headlines. Yahoo Finance+1 Below is a rundown of the most current
9 December 2025
Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group (CRDO) Stock: Earnings Blowout, AI Tailwinds, and What Comes Next

Credo Technology Group Holding Ltd (NASDAQ: CRDO) has turned into one of the most closely watched semiconductor names of late, thanks to explosive earnings growth and its strategic position in high-speed connectivity for AI data centers. As of 9 December 2025, the stock is trading around $168–170 per share, down from a recent all-time high above $210 but still miles above its 52-week low near $29. Investing.com In this deep dive, we’ll walk through the latest news, earnings, analyst forecasts, and key risks so you can understand why CRDO is suddenly everywhere in markets coverage. 1. Where CRDO Stands Today
Linde plc (LIN) Stock on December 9, 2025: 52‑Week Low, CEO Buying and Double‑Digit Upside Price Targets

Linde plc (LIN) Stock on December 9, 2025: 52‑Week Low, CEO Buying and Double‑Digit Upside Price Targets

Linde plc (NASDAQ: LIN), the world’s largest industrial gases company, is having a pivotal moment in the market. On December 9, 2025, the stock is trading near fresh 52‑week lows at the same time its CEO is buying nearly $1 million worth of shares, short interest is creeping higher, and Wall Street still sees sizeable upside over the next 12 months. Below is a full roundup of today’s news, forecasts, and analysis — plus what it all could mean for Linde stock. Key takeaways for Linde stock today (9 December 2025) Linde stock price action on December 9, 2025 Market
9 December 2025
Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) has quietly turned into one of 2025’s wilder biotech stories: a tiny oncology name that’s run more than eightfold off its 52-week low, pulled back on a big equity raise, and now sits in the middle of a high-stakes bet on a single breast-cancer drug. Below is a structured look at OLMA stock today, the latest news, Street forecasts, and the key risks investors are debating as of December 9, 2025. OLMA stock today: price, performance and volatility As of the latest trade on December 9, 2025, Olema Pharmaceuticals shares change hands at around $26–27
9 December 2025
Legend Biotech (LEGN) Stock Hits New Lows: Oversold CAR-T Leader or Long-Term Opportunity?

Legend Biotech (LEGN) Stock Hits New Lows: Oversold CAR-T Leader or Long-Term Opportunity?

As of December 9, 2025, shares of Legend Biotech Corporation (NASDAQ: LEGN) are under heavy pressure even as the company posts strong growth from its flagship CAR-T therapy, CARVYKTI. Here’s a deep dive into the latest news, forecasts, analyst calls and technical signals that are driving sentiment around Legend Biotech stock today. Where Legend Biotech Stock Trades Now Legend Biotech’s American Depositary Shares (ADS) were recently trading around $24.1, down roughly 8% on the day and hovering near fresh 52-week lows. Benzinga On December 9, 2025, the stock: A company news brief from Investing.com highlighted that Legend Biotech shares hit
9 December 2025
Waystar Holding Corp (WAY) Hits 52-Week Low as Barclays Cuts Target – But Wall Street Still Sees Big Upside

Waystar Holding Corp (WAY) Hits 52-Week Low as Barclays Cuts Target – But Wall Street Still Sees Big Upside

December 9, 2025 Waystar Holding Corp (NASDAQ: WAY), the healthcare payments software provider, is back in the spotlight after a sharp sell-off pushed the stock to fresh 52-week lows on Tuesday, even as Wall Street analysts continue to project substantial upside over the next 12 months. Waystar Stock Today: Fresh Lows in a Volatile Session In Tuesday’s trading, Waystar shares slid to the low-$31 range, marking a new 52-week low and extending a multi-month downtrend. Intraday, the stock traded between roughly $31 and $33, down about 6% on the day and hovering just above its one-year low around $30.75.StockAnalysis+1 According
9 December 2025
Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Ferguson Enterprises (FERG) Stock Slides After Q1 2026 Earnings – What Today’s Sell-Off Means for Investors

Newport News, VA – December 9, 2025 Ferguson Enterprises Inc. (NYSE: FERG; LSE: FERG) shares are under pressure today after the company reported results for the quarter ended October 31, 2025 (its fiscal Q1 2026). The numbers show solid operational momentum and raised full-year guidance, but the stock is trading sharply lower as investors digest valuations and future growth expectations. Below is a deep dive into today’s earnings, market reaction, analyst forecasts, and what it could mean for Ferguson stock going into 2026. 1. What Ferguson Reported Today Ferguson’s latest quarter was, in pure fundamental terms, strong: The company attributed
Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging (GPK) Stock Hits 52-Week Low as Earnings Guidance Cut and CEO Transition Rattle Investors

Graphic Packaging Holding Company (NYSE: GPK) — a major player in sustainable consumer packaging — is having a rough day on Wall Street. As of December 9, 2025, the stock has slid to a new 52-week low after the company cut its full-year earnings outlook, announced cost and production optimization measures, and confirmed a CEO transition set for early 2026. Investing.com India+1 Below is a detailed look at what’s happening with GPK stock today, the latest company news, analyst forecasts, and what the current market narrative looks like. GPK Stock Today: New 52-Week Low and Heavy Trading On December 9,
Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems, Inc. (NYSE: INSP), a leading developer of implantable devices to treat obstructive sleep apnea, is back in the spotlight. As of December 9, 2025, the stock is trading near the upper end of its recent rebound, supported by strong third-quarter results, favorable reimbursement changes, and a series of analyst upgrades—while simultaneously facing a fresh class-action investigation and lingering questions about growth and valuation. investors.inspiresleep.com+1 INSP stock on December 9, 2025: price action and recent volatility On December 9, 2025, Inspire Medical Systems shares are changing hands at about $141.72, down slightly on the day after touching an
9 December 2025
Advance Auto Parts (AAP) Stock Slides After Target Cut – Does the 2025 Turnaround Still Hold Up?

Advance Auto Parts (AAP) Stock Slides After Target Cut – Does the 2025 Turnaround Still Hold Up?

(for SEO):Advance Auto Parts (NYSE:AAP) stock is down sharply on December 9, 2025 after an analyst price-target cut and weak peer earnings. Here’s the latest on earnings, guidance, dividend, analyst forecasts and the ongoing three-year turnaround plan. Market snapshot: A rough day for Advance Auto Parts stock Advance Auto Parts, Inc. (NYSE: AAP) is back under pressure in Tuesday’s session (December 9, 2025). By midday, AAP shares were trading in the high-$40s, down roughly 7% on the day, in sympathy with sector peer AutoZone’s earnings miss and a fresh price-target cut from Evercore ISI.The Motley Fool+1 According to recent data,
Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

As of December 9, 2025, Kontoor Brands, Inc. (NYSE: KTB) — the parent company behind Wrangler, Lee and Helly Hansen — sits in an interesting sweet spot: strong fundamentals, bullish analyst targets, but a share price that’s been knocked around by broader consumer and interest-rate worries. Below is a detailed rundown of today’s news, recent earnings, analyst forecasts and valuation debates around KTB stock, written for readers who care about both headlines and numbers. Where KTB Stock Stands Today Different data providers will print slightly different real-time prices, but today KTB is trading in the mid-$70s per share, with intraday
AutoZone (AZO) Stock Plunges After Q1 2026 Earnings Miss — What Investors Need to Know Today

AutoZone (AZO) Stock Plunges After Q1 2026 Earnings Miss — What Investors Need to Know Today

December 9, 2025 AutoZone, Inc. (NYSE: AZO) is back in the headlines — and not in the way existing shareholders were hoping. After posting fiscal Q1 2026 results that showed solid sales growth but weaker profitability, AutoZone stock sold off sharply on Tuesday, becoming one of the worst performers in the S&P 500. The move comes despite continued same-store sales momentum, aggressive store expansion, and a long-term growth story that Wall Street still largely likes. This is the classic “great business, imperfect quarter” situation — which markets tend to overreact to. AutoZone stock today: sharp sell-off after earnings In Tuesday’s
Stock Market Today: Wall Street Rises as Fed Cut Looms, Nvidia Gets China Nod

Stock Market Today: Wall Street Rises as Fed Cut Looms, Nvidia Gets China Nod

U.S. stocks edge higher on December 9, 2025, as traders await a widely expected Fed rate cut, digest Nvidia’s conditional China chip approval and a bidding war for Warner Bros. Key points Fed meeting sets the tone for Wall Street Wall Street’s mild rebound comes at the start of one of the most important policy weeks of 2025. The Federal Reserve kicked off its final two‑day meeting of the year on Tuesday, with investors almost certain it will cut the federal funds rate by 25 basis points on Wednesday, to a target range around 3.50%–3.75%. Reuters+1 Futures markets tracked by CME’s
D-Wave Quantum (QBTS) Stock in December 2025: Rally, Volatility, and What Analysts Expect Next

D-Wave Quantum (QBTS) Stock in December 2025: Rally, Volatility, and What Analysts Expect Next

D-Wave Quantum Inc. (NYSE: QBTS) has become one of 2025’s wildest technology stories: a tiny quantum computing pure play whose share price has rocketed, crashed, and then bounced again in the space of a few months. As of December 9, 2025, the stock is back on the move, analysts are lifting price targets, and big institutional names are showing up on the shareholder list. Yahoo Finance Below is a rundown of the latest news, forecasts, and key metrics on D-Wave Quantum stock as of today, structured for readers watching the name on Google News and Discover. Where D-Wave Quantum Stock
Hawaiian Electric Industries (HE) Stock Soars on S&P 600 Inclusion – Latest News, Maui Settlement Update and 2026 Forecasts

Hawaiian Electric Industries (HE) Stock Soars on S&P 600 Inclusion – Latest News, Maui Settlement Update and 2026 Forecasts

Hawaiian Electric Industries, Inc. (NYSE: HE) is back in the headlines. After spending more than a year under intense pressure from the 2023 Maui wildfires and multi-billion-dollar legal risks, HE stock just logged a sharp rally driven by a powerful technical catalyst: inclusion in a major equity index. As of December 9, 2025, Hawaiian Electric Industries stock trades around $11.73 per share, giving the company a market capitalization of roughly $2.1 billion. At the same time, the company is moving closer to finalizing a $4+ billion global settlement tied to the Maui fires, while analysts remain cautious with a consensus
Wells Fargo (WFC) Stock Near Record High: AI Job Cuts, $40B Buyback and Regulatory Relief Shape 2025 Outlook

Wells Fargo (WFC) Stock Near Record High: AI Job Cuts, $40B Buyback and Regulatory Relief Shape 2025 Outlook

Wells Fargo & Company (NYSE: WFC) is trading just under record highs around $89–$90 per share as investors digest a fresh wave of news: CEO comments about AI‑driven job cuts, a new Piper Sandler price target of $100, progress on a major $84 million 401(k) settlement, and continuing capital returns via dividends and a $40 billion buyback program.MarketScreener+1 Below is a structured look at what’s new on 9 December 2025, how it fits into the bigger story for Wells Fargo stock, and what analysts currently expect. Note: This article is for information and education only and is not investment advice.
Verizon (VZ) Stock on December 9, 2025: High‑Yield Dividend, 13,000+ Layoffs and a New CEO at a Turning Point

Verizon (VZ) Stock on December 9, 2025: High‑Yield Dividend, 13,000+ Layoffs and a New CEO at a Turning Point

Published: December 9, 2025 – All data and news as of this date. This article is for information only and not investment advice. Verizon stock today: price, performance and yield Verizon Communications Inc. (NYSE: VZ) remains one of the market’s most closely watched income stocks as 2025 draws to a close. On a total‑return basis, Verizon is up roughly 10% year‑to‑date in 2025, but its 1‑year return is only about 2–4%, far behind the S&P 500’s ~13% over the same period. Finance Charts+1 Despite the modest share‑price performance, Verizon’s attraction for many investors is clear: a dividend yield in the
9 December 2025
Ciena (CIEN) Stock Soars to Record Highs Ahead of Q4 2025 Earnings: Is the AI Network Boom Already Priced In?

Ciena (CIEN) Stock Soars to Record Highs Ahead of Q4 2025 Earnings: Is the AI Network Boom Already Priced In?

As of December 9, 2025, Ciena Corporation (NYSE: CIEN) is trading like a company plugged straight into the heart of the AI infrastructure boom. The stock recently changed hands around $216–217, after touching an intraday high near $220, and has notched a fresh 52-week high above $214.Investing.com Over the past twelve months, CIEN shares are up roughly 190%, a staggering rerating for a once-sleepy optical networking name.Investing.com At the same time, Wall Street is rapidly rewriting its spreadsheets: multiple analysts have lifted their price targets in the last week, just two days before Ciena reports fiscal Q4 and full-year 2025

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop